This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2022.
All research outputs
#10,059,416
of 29,281,147 outputs
Outputs from Diabetes Technology & Therapeutics
#978
of 1,804 outputs
Outputs of similar age
#17,400
of 47,733 outputs
Outputs of similar age from Diabetes Technology & Therapeutics
#7
of 13 outputs
Altmetric has tracked 29,281,147 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,804 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.6. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 47,733 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 8th percentile – i.e., 8% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
